

HY-120726 · 50 mg
MedChemExpress · Cat: HY-120726
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bf844.html
Description
BF844 mitigate hearing loss associated with USH3 usher syndrome type III mutation CLRN1 clarin-1 N48K. BF844 induces CLRN1N48K transportes to the plasma membrane. BF844 shows significantly preserves hearing in vivo.





